@prefix cas: <http://identifiers.org/cas/> .
@prefix chemspider: <http://identifiers.org/chemspider/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix pubchem: <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-Athens_Univ-AU209408 a mbo:MassSpectrum ;
    dcterms:creator "Nikiforos Alygizakis, Nikolaos Thomaidis, University of Athens" ;
    dcterms:date "2016-02-26"^^xsd:date ;
    dcterms:identifier "MSBNK-Athens_Univ-AU209408" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights "Copyright (C) 2016 Department of Chemistry, University of Athens under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "Bruker maXis Impact" ;
            mbo:collision_energy "20 eV" ;
            mbo:column_name "ACQUITY UPLC BEH Amide 1.7 um 2.1x100mm, Waters" ;
            mbo:flow_gradient "0/100 at 0-2 min, 95/5 at 12 min, 95/5 at 17 min, 0/100 at 17.1, 0/100 at 25 min" ;
            mbo:flow_rate "200 uL/min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "35000" ;
            mbo:retention_time "1.616 min" ;
            mbo:solvent "A Water with 0.01% formic acid and 1mM ammonium formate",
                "B Acetonitrile:Water 95:5 with 0.01% formic acid and 1mM ammonium formate" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one",
                "Irbesartan" ;
            mbo:ch_compound_class "N/A; Environmental Standard" ;
            mbo:ch_exact_mass 4.282325e+02 ;
            rdfs:seeAlso cas:138402-11-6,
                chemspider:3618,
                pubchem:CID3749 ;
            schema:inChI "InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)" ;
            schema:inChIKey inchikey:YOSHYTLCDANDAN-UHFFFAOYSA-N ;
            schema:molecularFormula "C25H28N6O" ;
            schema:name "2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one",
                "Irbesartan" ;
            schema:smiles "CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1" ] ;
    mbo:has_peak [ mbo:intensity 2.63964e+05 ;
            mbo:mz 1.951505e+02 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 185 ],
        [ mbo:intensity 2.246e+04 ;
            mbo:mz 4.022392e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 16 ],
        [ mbo:intensity 1.42212e+06 ;
            mbo:mz 4.292436e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 995 ],
        [ mbo:intensity 3.22408e+05 ;
            mbo:mz 4.302467e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 225 ],
        [ mbo:intensity 3.5176e+04 ;
            mbo:mz 4.312489e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 25 ],
        [ mbo:intensity 2.7256e+04 ;
            mbo:mz 1.96153e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 19 ],
        [ mbo:intensity 1.428388e+06 ;
            mbo:mz 2.070932e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 1.43212e+05 ;
            mbo:mz 2.080962e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 100 ],
        [ mbo:intensity 8.216e+03 ;
            mbo:mz 2.090988e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 6 ],
        [ mbo:intensity 1.7216e+04 ;
            mbo:mz 2.35099e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 12 ],
        [ mbo:intensity 4.8944e+04 ;
            mbo:mz 3.862254e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 34 ],
        [ mbo:intensity 1.2112e+04 ;
            mbo:mz 3.872283e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 8 ],
        [ mbo:intensity 8.6744e+04 ;
            mbo:mz 4.012368e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 61 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 2.240702e+02 ;
            mbo:precursor_mz 4.292397e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 13 ;
    mbo:pk_splash "splash10-0a6r-0170900000-f3047a706723fc02bc24" ;
    rdfs:comment "INTERNAL_ID 2094" ;
    skos:definition "Irbesartan; LC-ESI-QTOF; MS2; HILIC; CE: 20 eV; R=35000; [M+H]+" .

